Diagnosis of Mucopolysaccharidosis Disorders in Patients Presenting With Bilateral Hip Disease

CompletedOBSERVATIONAL
Enrollment

22

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Mucopolysaccharidosis IV AMucopolysaccharidosis VI
Interventions
OTHER

Enzyme testing

Leukocyte activity measurement of Arylsulfatase B and N acetyl galactosamine 6 sulfatase (GALNS)

Trial Locations (2)

55101

Gillette Children's Specialty Healthcare, Saint Paul

55404

Children's Hospitals and Clinics of Minnesota, Minneapolis

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

BioMarin Pharmaceutical

INDUSTRY

collaborator

Greenwood Genetic Center

OTHER

collaborator

Gillette Children's Specialty Healthcare

OTHER

lead

Children's Hospitals and Clinics of Minnesota

OTHER